Works matching IS 09291903 AND DT 2012 AND VI 19 AND IP 6

Results: 8

Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor model.

Published in:

Cancer Gene Therapy, 2012, v. 19, n. 6, p. 431, doi. 10.1038/cgt.2012.21

By:

Thaci, B;
Ahmed, A U;
Ulasov, I V;
Tobias, A L;
Han, Y;
Aboody, K S;
Lesniak, M S

Publication type:

Article

Interferon-β lipofection II. Mechanisms involved in cell death and bystander effect induced by cationic lipid-mediated interferon-β gene transfer to human tumor cells.

Published in:

Cancer Gene Therapy, 2012, v. 19, n. 6, p. 420, doi. 10.1038/cgt.2012.19

By:

Villaverde, M S;
Gil-Cardeza, M L;
Glikin, G C;
Finocchiaro, L M E

Publication type:

Article

The radiation dose-regulated AND gate genetic circuit, a novel targeted and real-time monitoring strategy for cancer gene therapy.

Published in:

Cancer Gene Therapy, 2012, v. 19, n. 6, p. 382, doi. 10.1038/cgt.2012.11

By:

Ding, M;
Zhang, E;
He, R;
Wang, X;
Li, R;
Wang, W;
Yi, Q

Publication type:

Article

Targeted therapy via oral administration of attenuated Salmonella expression plasmid-vectored Stat3-shRNA cures orthotopically transplanted mouse HCC.

Published in:

Cancer Gene Therapy, 2012, v. 19, n. 6, p. 393, doi. 10.1038/cgt.2012.12

By:

Tian, Y;
Guo, B;
Jia, H;
Ji, K;
Sun, Y;
Li, Y;
Zhao, T;
Gao, L;
Meng, Y;
Kalvakolanu, D V;
Kopecko, D J;
Zhao, X;
Zhang, L;
Xu, D

Publication type:

Article

Phase 1/2a, dose-escalation, safety, pharmacokinetic and preliminary efficacy study of intratumoral administration of BC-819 in patients with unresectable pancreatic cancer.

Published in:

Cancer Gene Therapy, 2012, v. 19, n. 6, p. 374, doi. 10.1038/cgt.2012.10

By:

Hanna, N;
Ohana, P;
Konikoff, F M;
Leichtmann, G;
Hubert, A;
Appelbaum, L;
Kopelman, Y;
Czerniak, A;
Hochberg, A

Publication type:

Article

Combining transfer of TTF-1 and Pax-8 gene: a potential strategy to promote radioiodine therapy of thyroid carcinoma.

Published in:

Cancer Gene Therapy, 2012, v. 19, n. 6, p. 402, doi. 10.1038/cgt.2012.13

By:

Mu, D;
Huang, R;
Li, S;
Ma, X;
Lou, C;
Kuang, A

Publication type:

Article

Human amniotic fluid-derived stem cells expressing cytosine deaminase and thymidine kinase inhibits the growth of breast cancer cells in cellular and xenograft mouse models.

Published in:

Cancer Gene Therapy, 2012, v. 19, n. 6, p. 412, doi. 10.1038/cgt.2012.15

By:

Kang, N-H;
Hwang, K-A;
Yi, B-R;
Lee, H J;
Jeung, E-B;
Kim, S U;
Choi, K-C

Publication type:

Article

Nanovector delivery of siRNA for cancer therapy.

Published in:

Cancer Gene Therapy, 2012, v. 19, n. 6, p. 367, doi. 10.1038/cgt.2012.22

By:

Shen, H;
Sun, T;
Ferrari, M

Publication type:

Article